Gastrointestinal Stromal Tumor — Trials

Gastrointestinal Stromal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

341 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05080621	Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)	withdrawn	Phase 1 / Phase 2	0	Deciphera Pharmaceuticals, LLCINDUSTRY	0	Jan 5, 2022	clinicaltrials
NCT02342600	SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)	withdrawn	Phase 2	0	Sarcoma Alliance for Research through CollaborationOTHER	0	Oct 12, 2017	clinicaltrials